The first of the two injections to be evaluated Qilu has reached 11 injections

Data monitoring, February 2, Qilu's hydrochloric acid Iliticon injection, hydrochloric acid Andansjong injection through a consistent evaluation, for the first evaluation of enterprises;
, Qilu and its subsidiaries have evaluated 11 injections, and there are still 19 applications for consistent evaluation of injections in the review and approval.
Injection with fusapiram double glucosamine fusaphamine is a neuro-exciting peptide-1 (NK-1) patient antagonist, is the pre-drug of aspirin, with a new mechanism of action, affirmation of efficacy, high safety, pro widely applicable and so on.
as a clinically in urgent need of drugs, Fusapitan double glucosamine was included in China's "first batch of encouraging generic drugs directory."
in combination with other anti-spitting drugs, it is suitable for adult patients to prevent acute and late nausea and vomiting during the initial and repeated treatment of highly vomiting chemotherapy drugs.
the current domestic clinical chemotherapy anti-spitting drugs are mainly 5-HT3 subject antagonists, its anti-spitting effect is obvious, but due to the different degree of vomiting and difficult to fully effective control.
the emergence of fusapitan double glucosal aureus makes chemotherapy-related nausea and vomiting treatment from the so-called "5-HT3 subject antagonist era" into a new era, with huge market space.
Fusapitan double glucosamine - domestic listed companies are understood to have sales of US$360 million in the global market in 2018.
data show that both Howson and Zhengda Tianqing were approved for listing in 2019, Howson was approved according to three types of imitation and the same evaluation, Qilu also according to the new classification and approved, becoming the second enterprise to be evaluated.
Hydrochloric acid Ilidikang injection hydrochloric acid Ilitisan injection is suitable for the treatment of patients with advanced colorectal cancer, the original research drug developed by Pfizer, domestic manufacturers are mainly Hainan Jinrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceutical Co., Ltd., Ha Pharmaceutical Group bioengineering.
reported that the 2019 global sales of hydrochloric acid Ilidekang injections were US$64,645.2 million, of which sales in China were US$138.7939 million.
the current domestic hydrochloric acid Elitekang injection approval has 26, a number of enterprises listed for production.
declare consistency evaluation of enterprises only Qilu Pharmaceuticals and Jiangsu Hengrui, and Qilu Pharmaceutical's processing status is "approved", Jiangsu Hengrui one of the acceptance numbers has also shown "send", in addition, the two enterprises have been approved by the FDA listing.
hydrochloric acid ondansjong injection hydrodamsjung injections belong to the digestive system and metabolic drugs, used for nausea and vomiting caused by chemotherapy and radiation therapy for cytotoxic drugs.
hydrochloric acid antains, adaptive products are used to control nausea and vomiting in combination with chemotherapy and radiation therapy for cancer, and are also suitable for prevention and post-surgery nausea and vomiting.
: Children over 4 years of age: nausea and vomiting together with chemotherapy and radiotherapy to control cancer.
4 years of age: nausea and vomiting caused by chemotherapy to control cancer.
over 2 years of age: prevention and treatment of nausea and vomiting after surgery.
as early as 1994, Qilu Pharmaceuticals in china's first imitation of the listing of hydrochloric acid Ondansjung injections due to good quality, outstanding safety, clinical effects and other advantages, since the listing of the first stable domestic market share.
2014, the hydrochloric acid Ondansjong injection was successfully approved in the United States.
ranked fifth among end-of-life anti-spitting and anti-nausea injection products in China's public medical institutions in 2019, with sales of more than 600 million yuan.
's total share of more than 70% is hard to shake.
injection data sources that have been consistently evaluated by Qilu: Radon data